Login or sign up
For business
Average ratingGreat
4.0/ 5

Based on 7 reviews

529%
443%
329%
20%
10%
Ask AI

Ask AI about Xytis

Generated with AI from 7 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Joonho Yoon
Reviews 1

I recently purchased a product from xytis.com and I am very satisfied with my purchase. The product is of great quality and met my expectations. The website was easy to use and the checkout process was smooth. I would definitely recommend this company for their excellent products and services.

Nicki Bryant
Reviews 1

I recently made a purchase from the company's website and I am really pleased with the whole experience. The website was user-friendly and the ordering process was smooth. The product arrived quickly and was exactly what I expected. I would definitely buy from them again.

Rahul Sankaran
Reviews 1

Xytis is a great company to work with. Their website xytis.com is user-friendly and easy to navigate. The team at Xytis is highly professional and I have always received prompt and efficient service from them. I would highly recommend Xytis to anyone looking for reliable and high-quality products.

Marco Pulvirenti
Reviews 1

I have been a customer of Xytis for several years now and I must say that I am impressed with their products and customer service. The website xytis.com is easy to navigate and has a great selection of products. The team at Xytis is always helpful and responsive to any inquiries or issues. I highly recommend them!

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Xytis

Xytis is a biopharmaceutical company focusing on the discovery and development of innovative CNS drug candidates. The company is privately held and was created in Jan 2006 by the merger of Xytis Pharmaceuticals Ltd. (UK) and Remergent, Inc. (USA). The company received funding from Sanderling Ventures, Atlas Venture, CDC Entreprises Innovation, and Ventech. Xytis Inc. is assembling a pipeline of innovative compounds with validated mechanisms of action, addressing major unmet clinical needs in CNS fields such as Schizophrenia, Traumatic Brain Injury, Depression, Anxiety, or Insomnia. The company has two clinical stage compounds in development and operates from the USA, UK and Switzerland.

Website
xytis.com